No abstract available
Publication types
-
Clinical Trial, Phase II
-
Letter
-
Randomized Controlled Trial
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Bleomycin / adverse effects
-
Bleomycin / therapeutic use
-
Dacarbazine / adverse effects
-
Dacarbazine / therapeutic use
-
Doxorubicin / adverse effects
-
Doxorubicin / therapeutic use
-
Hodgkin Disease / diagnosis
-
Hodgkin Disease / drug therapy*
-
Hodgkin Disease / mortality
-
Humans
-
Neoplasm Metastasis
-
Neoplasm Staging
-
Rituximab / administration & dosage
-
Treatment Outcome
-
Vinblastine / adverse effects
-
Vinblastine / therapeutic use
Substances
-
Bleomycin
-
Rituximab
-
Vinblastine
-
Dacarbazine
-
Doxorubicin